Details for 2015787846

Up to date per 01.04.2026

Actions

Title / Product Name

KRISTALLINE FORMEN VON 5-CHLORO-N4-[2-(DIMETNHYLPHOSPHORYL)PHENYL]-N2-(2-METHOXY-4-[4-(4-METHYLPIPERAZIN-1-YL)PIPERIDIN-A-YL]PYRIMIDIN-2,4-DIAMIN

Status

Granted/Registered

Protection Type

European Patent

(AT-) Application Number

2015787846

EP Publication Number

3209647

E-Number

1276883

Language

PCT Number

US15056701

Publication Date

30.08.2017 A

03.06.2020 B1

Registration Date

03.06.2020

AT Publication Date

15.06.2020

Application Date

21.10.2015

Registration Number

Priorities

21.10.2014

201462066849 P

IPC

C07D 239/48 20060101AFI20160503BHEP

Maximum Duration of Protection

21.10.2035

Owner

Takeda Pharmaceutical Company Limited1-1, Doshomachi 4-chome, Chuo-ku, Osaka-shi OsakaJP

Representative

No representatives present

Inventor

ROZAMUS, Leonard, W.1 Stouffer Circle Andover, MA 01810US

SHARMA, Pradeep25 Fletcher Road Westford, MA 01886US

Information about Fees